A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

NCT06066138 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

NIH

Sponsor class

Conditions

Locally Advanced Alveolar Soft Part Sarcoma
Metastatic Alveolar Soft Part Sarcoma
Locally Advanced Non Small Cell Lung Cancer
Metastatic Non Small Cell Lung Cancer
Locally Advanced Small Cell Lung Cancer
Metastatic Small Cell Lung Cancer
Locally Advanced Hepatocellular Carcinoma
Metastatic Hepatocellular Carcinoma
Locally Advanced Melanoma
Metastatic Melanoma

Interventions

DRUG: Atezolizumab

Sponsor

National Cancer Institute (NCI)